My guess is there is something good coming, and the high bids in the "after market" worried the company that there had been a leak.Those bids might get some attention.Fingers crossed.
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
